comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-23 18:37:23 - browse：57

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： YouTube cracks down on misinformation on cancer treatment

WSS

Senators push IRS to launch nonprofit hospital probe

Aspartame and sugar

Nobel honors Karikó and Weissman's enduring partnership

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Flu, Covid vaccination rates decline, new survey data show

Biogen’s boardroom scandal saddles CEO with first crisis

hotspot

comprehensive

Sign up for D.C. Diagnosis

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

YouTube cracks down on misinformation on cancer treatment

Walensky prepares to leave CDC — and Congress — behind

Surge in Apellis stock fueled by confidence in safety of its eye drug

Walensky prepares to leave CDC — and Congress — behind

Indictment alleges Trump's ex

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Setback for rare diseases as Taysha Gene Therapies pulls back

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mark Cuban is blaming the wrong people for high drug costs

hotspot

Nobel honors Karikó and Weissman's enduring partnership

Megan Rapinoe shares emotional post following US Women's World Cup exit

IVG is promising — but it won’t replace IVF quite yet

Indictment alleges Trump's ex

Biogen’s boardroom scandal saddles CEO with first crisis

Be careful with at

focus

knowledge

hotspot

Wikipedia